Zaloguj się

Gotowe bibliografie tematyczne / Neuromuscular transmission / Artykuły w czasopismach

Artykuły w czasopismach na temat „Neuromuscular transmission”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Neuromuscular transmission.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 2 marca 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Neuromuscular transmission”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

MacLean, Ian C. "Neuromuscular Transmission". Physical Medicine and Rehabilitation Clinics of North America 1, nr 1 (listopad 1990): 43–52. http://dx.doi.org/10.1016/s1047-9651(18)30745-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Parker, C. "Neuromuscular transmission". Postgraduate Medical Journal 74, nr 870 (1.04.1998): 255. http://dx.doi.org/10.1136/pgmj.74.870.255-a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Torda, T. A. "Monitoring Neuromuscular Transmission". Anaesthesia and Intensive Care 30, nr 2 (kwiecień 2002): 123–33. http://dx.doi.org/10.1177/0310057x0203000202.

Pełny tekst źródła

Streszczenie:

Persistent neuromuscular blockade is not uncommon in the recovery room and contributes to postoperative morbidity and possibly mortality. The use of neuromuscular monitoring and intermediate rather than long-acting neuromuscular blocking drugs have been shown to reduce its incidence. Clinically available methods of detecting and quantitating neuromuscular blockade are reviewed. The writer concludes that such monitoring should be routine when neuromuscular blocking drugs are used.

Style APA, Harvard, Vancouver, ISO itp.

4

Beemer, G. H., i P. H. Goonetilleke. "Monitoring neuromuscular transmission". Current Anaesthesia & Critical Care 7, nr 2 (kwiecień 1996): 101–6. http://dx.doi.org/10.1016/s0953-7112(96)80065-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Pascuzzi, Robert. "Disorders of Neuromuscular Transmission". Seminars in Neurology 24, nr 02 (15.07.2004): 137. http://dx.doi.org/10.1055/s-2004-830898.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Weissman, J. D. "Electromyography: Neuromuscular Transmission Studies". Neurology 39, nr 8 (1.08.1989): 1141. http://dx.doi.org/10.1212/wnl.39.8.1141-b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Meistelman, Claude. "Monitoring of neuromuscular transmission". Current Opinion in Anaesthesiology 6, nr 4 (sierpień 1993): 720–25. http://dx.doi.org/10.1097/00001503-199308000-00024.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Wareham, Anthony C. "Neuromuscular function and transmission". Anaesthesia & Intensive Care Medicine 6, nr 6 (czerwiec 2005): 203–5. http://dx.doi.org/10.1383/anes.6.6.203.65787.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Krendel, David. "Hypermagnesemia and Neuromuscular Transmission". Seminars in Neurology 10, nr 01 (marzec 1990): 42–45. http://dx.doi.org/10.1055/s-2008-1041252.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

WINDSOR, J. P. W., P. S. SEBEL i P. J. FLYNN. "The neuromuscular transmission monitor". Anaesthesia 40, nr 2 (22.02.2007): 146–51. http://dx.doi.org/10.1111/j.1365-2044.1985.tb10705.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Henning, R. H. "Purinoceptors in neuromuscular transmission". Pharmacology & Therapeutics 74, nr 1 (styczeń 1997): 115–28. http://dx.doi.org/10.1016/s0163-7258(97)00015-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Fletcher, Allan. "Neuromuscular function and transmission". Anaesthesia & Intensive Care Medicine 9, nr 6 (czerwiec 2008): 256–58. http://dx.doi.org/10.1016/j.mpaic.2008.04.005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Fletcher, Allan. "Neuromuscular function and transmission". Anaesthesia & Intensive Care Medicine 12, nr 6 (czerwiec 2011): 245–48. http://dx.doi.org/10.1016/j.mpaic.2011.03.012.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

MAELICKE, ALFRED, T. COBAN, A. SCHRATTENHOLZ, B. SCHRÖDER, S. REINHARDT-MAELICKE, A. STORCH, J. GODOVAC-ZIMMERMANN, CHRISTOPH METHFESSEL, E. F. R. PEREIRA i EDSON X. ALBUQUERQUE. "Physostigmine and Neuromuscular Transmission". Annals of the New York Academy of Sciences 681, nr 1 Myasthenia Gr (czerwiec 1993): 140–54. http://dx.doi.org/10.1111/j.1749-6632.1993.tb22880.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Martin, A. Robert. "Principles of Neuromuscular Transmission". Hospital Practice 27, nr 8 (15.08.1992): 147–58. http://dx.doi.org/10.1080/21548331.1992.11705473.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Torda, T. A. "Book Review: Neuromuscular Transmission." Anaesthesia and Intensive Care 29, nr 4 (sierpień 2001): 439. http://dx.doi.org/10.1177/0310057x0102900420.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Hirst, G. D. S., S. De Gleria i D. F. van Helden. "Neuromuscular transmission in arterioles". Experientia 41, nr 7 (lipiec 1985): 874–79. http://dx.doi.org/10.1007/bf01970004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Sherman, Howard B. "Electromyography: Neuromuscular transmission studies". Surgical Neurology 31, nr 2 (luty 1989): 163. http://dx.doi.org/10.1016/0090-3019(89)90336-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Schelhaas, H. Jurgen, Bart P. C. Van De Warrenburg, Hubertus P. H. Kremer i Machiel J. Zwarts. "Neuromuscular transmission in SCA6". Annals of Neurology 55, nr 3 (2004): 451–52. http://dx.doi.org/10.1002/ana.20015.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Pascuzzi, Robert. "Introduction to the Neuromuscular Junction and Neuromuscular Transmission". Seminars in Neurology 10, nr 01 (marzec 1990): 1–5. http://dx.doi.org/10.1055/s-2008-1041246.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

UEDA, NAOYUKI. "Clinical Assessment of Neuromuscular Transmission." JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 15, nr 3 (1995): 197–201. http://dx.doi.org/10.2199/jjsca.15.197.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Vincent, Angela. "Autoantibodies in neuromuscular transmission disorders". Annals of Indian Academy of Neurology 11, nr 3 (2008): 140. http://dx.doi.org/10.4103/0972-2327.42932.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Fagerlund, M. J., i L. I. Eriksson. "Current concepts in neuromuscular transmission". British Journal of Anaesthesia 103, nr 1 (lipiec 2009): 108–14. http://dx.doi.org/10.1093/bja/aep150.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Marshall, Ian G. "Prejunctional aspects of neuromuscular transmission". Current Opinion in Anaesthesiology 4, nr 4 (sierpień 1991): 577–82. http://dx.doi.org/10.1097/00001503-199108000-00021.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Martyn, J. A. J., M. Jonsson Fagerlund i L. I. Eriksson. "Basic principles of neuromuscular transmission". Anaesthesia 64 (marzec 2009): 1–9. http://dx.doi.org/10.1111/j.1365-2044.2008.05865.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Engel, Andrew. "Congenital Disorders of Neuromuscular Transmission". Seminars in Neurology 10, nr 01 (marzec 1990): 12–26. http://dx.doi.org/10.1055/s-2008-1041248.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Lange, D. J. "Electrophysiologic testing of neuromuscular transmission". Neurology 48, Supplement 5 (1.04.1997): 18S—22S. http://dx.doi.org/10.1212/wnl.48.suppl_5.18s.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Sieb, J. P. "Fluoroquinolone antibiotics block neuromuscular transmission". Neurology 50, nr 3 (1.03.1998): 804–7. http://dx.doi.org/10.1212/wnl.50.3.804.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

JONES, R. M. "Neuromuscular transmission and its blockade." Anaesthesia 40, nr 10 (październik 1985): 964–76. http://dx.doi.org/10.1111/j.1365-2044.1985.tb10551.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Schulze, J., M. Toepfer, K.-C. Schroff, S. Aschhoff, J. Remien, W. Müller-Felber i S. Endres. "Clindamycin and nicotinic neuromuscular transmission". Lancet 354, nr 9192 (listopad 1999): 1792–93. http://dx.doi.org/10.1016/s0140-6736(99)02881-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Enomoto, Koh-Ichi, i Charles Edwards. "Thiamine blockade of neuromuscular transmission". Brain Research 358, nr 1-2 (grudzień 1985): 316–23. http://dx.doi.org/10.1016/0006-8993(85)90976-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Kaminski, Henry J., i Robert L. Ruff. "Congenital Disorders of Neuromuscular Transmission". Hospital Practice 27, nr 9 (15.09.1992): 73–85. http://dx.doi.org/10.1080/21548331.1992.11705484.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Mahadeva, Branavan, Lawrence Phillips i Vern Juel. "Autoimmune Disorders of Neuromuscular Transmission". Seminars in Neurology 28, nr 2 (kwiecień 2008): 212–27. http://dx.doi.org/10.1055/s-2008-1062260.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Saldien, V., i K. M. Vermeyen. "Neuromuscular transmission monitoring in children". Pediatric Anesthesia 14, nr 4 (kwiecień 2004): 289–92. http://dx.doi.org/10.1046/j.1460-9592.2003.01152.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Sieb, Jo¨rn P., i Andrew G. Engel. "Ephedrine: effects on neuromuscular transmission". Brain Research 623, nr 1 (wrzesień 1993): 167–71. http://dx.doi.org/10.1016/0006-8993(93)90025-i.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Sanders, D. B. "WS6-1 Neuromuscular transmission — overview". Clinical Neurophysiology 121 (październik 2010): S79. http://dx.doi.org/10.1016/s1388-2457(10)60335-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Kurenkov, D. A., S. Yu Chizhevskaya i E. M. Nikolaenko. "Objective monitoring of neuromuscular transmission in laparoscopic surgery". Kazan medical journal 94, nr 6 (15.12.2013): 866–69. http://dx.doi.org/10.17816/kmj1808.

Pełny tekst źródła

Streszczenie:

Aim. To assess the importance of quantitative neuromuscular transmission monitoring in laparoscopic surgery. Methods. 30 patients [11 (37.7%) males, 19 (63.3%) females, mean age 52.3±7.18 years] who underwent laparoscopic surgery and general anesthesia associated with skeletal muscles relaxation, were examined. The degree of neuromuscular transmission recovery and time to trachea extubation performed by an anesthetist after the end of surgery (like laparoscopic cholecystectomy, appendectomy) and general anesthesia associated with skeletal muscles relaxation were assessed using quantitative monitoring of neuromuscular transmission and «blind» control. Results. In 21 patients no drugs were used to reverse the skeletal muscles relaxation. Trachea extubation in this group was performed 10.5 minutes after the end of surgery in average at the neuromuscular transmission Train of Four (TOF) level of 43-81% for 15 patients and at the TOF level over 90% in 6 patients. In 9 patients, sugammadex (2 mg/kg) was used for neuromuscular transmission reversal, the average level of neuromuscular blockade (TOF) in those patients was 41±6.5%. TOF average recovery time up to 90% was 1 minute 48 seconds. Trachea extubation was performed no later than 4 minutes after the sugammadex administration. Conclusion. The subjective assessment of neuromuscular transmission recovery, based on the assessment of clinical signs, is not able to completely exclude the residual muscle relaxation. Objective monitoring of neuromuscular transmission is required to determine the time of intubation, administration of maintenance doses of muscle relaxants, and for assessment of efficacy of reversal and possibility for trachea extubation.

Style APA, Harvard, Vancouver, ISO itp.

38

Fogarty, Matthew J., Maria A. Gonzalez Porras, Carlos B. Mantilla i Gary C. Sieck. "Diaphragm neuromuscular transmission failure in aged rats". Journal of Neurophysiology 122, nr 1 (1.07.2019): 93–104. http://dx.doi.org/10.1152/jn.00061.2019.

Pełny tekst źródła

Streszczenie:

In aging Fischer 344 rats, phrenic motor neuron loss, neuromuscular junction abnormalities, and diaphragm muscle (DIAm) sarcopenia are present by 24 mo of age, with larger fast-twitch fatigue-intermediate (type FInt) and fast-twitch fatigable (type FF) motor units particularly vulnerable. We hypothesize that in old rats, DIAm neuromuscular transmission deficits are specific to type FInt and/or FF units. In phrenic nerve/DIAm preparations from rats at 6 and 24 mo of age, the phrenic nerve was supramaximally stimulated at 10, 40, or 75 Hz. Every 15 s, the DIAm was directly stimulated, and the difference in forces evoked by nerve and muscle stimulation was used to estimate neuromuscular transmission failure. Neuromuscular transmission failure in the DIAm was observed at each stimulation frequency. In the initial stimulus trains, the forces evoked by phrenic nerve stimulation at 40 and 75 Hz were significantly less than those evoked by direct muscle stimulation, and this difference was markedly greater in 24-mo-old rats. During repetitive nerve stimulation, neuromuscular transmission failure at 40 and 75 Hz worsened to a greater extent in 24-mo-old rats compared with younger animals. Because type IIx and/or IIb DIAm fibers (type FInt and/or FF motor units) display greater susceptibility to neuromuscular transmission failure at higher frequencies of stimulation, these data suggest that the age-related loss of larger phrenic motor neurons impacts nerve conduction to muscle at higher frequencies and may contribute to DIAm sarcopenia in old rats. NEW & NOTEWORTHY Diaphragm muscle (DIAm) sarcopenia, phrenic motor neuron loss, and perturbations of neuromuscular junctions (NMJs) are well described in aged rodents and selectively affect FInt and FF motor units. Less attention has been paid to the motor unit-specific aspects of nerve-muscle conduction. In old rats, increased neuromuscular transmission failure occurred at stimulation frequencies where FInt and FF motor units exhibit conduction failures, along with decreased apposition of pre- and postsynaptic domains of DIAm NMJs of these units.

Style APA, Harvard, Vancouver, ISO itp.

39

Krivoi, Igor, i Alexey Petrov. "Cholesterol and the Safety Factor for Neuromuscular Transmission". International Journal of Molecular Sciences 20, nr 5 (28.02.2019): 1046. http://dx.doi.org/10.3390/ijms20051046.

Pełny tekst źródła

Streszczenie:

A present review is devoted to the analysis of literature data and results of own research. Skeletal muscle neuromuscular junction is specialized to trigger the striated muscle fiber contraction in response to motor neuron activity. The safety factor at the neuromuscular junction strongly depends on a variety of pre- and postsynaptic factors. The review focuses on the crucial role of membrane cholesterol to maintain a high efficiency of neuromuscular transmission. Cholesterol metabolism in the neuromuscular junction, its role in the synaptic vesicle cycle and neurotransmitter release, endplate electrogenesis, as well as contribution of cholesterol to the synaptogenesis, synaptic integrity, and motor disorders are discussed.

Style APA, Harvard, Vancouver, ISO itp.

40

Ermilov, Leonid G., Juan N. Pulido, Fawn W. Atchison, Wen-Zhi Zhan, Mark H. Ereth, Gary C. Sieck i Carlos B. Mantilla. "Impairment of diaphragm muscle force and neuromuscular transmission after normothermic cardiopulmonary bypass: effect of low-dose inhaled CO". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 298, nr 3 (marzec 2010): R784—R789. http://dx.doi.org/10.1152/ajpregu.00737.2009.

Pełny tekst źródła

Streszczenie:

Cardiopulmonary bypass (CPB) is associated with significant postoperative morbidity, but its effects on the neuromuscular system are unclear. Recent studies indicate that even relatively short periods of mechanical ventilation result in significant neuromuscular effects. Carbon monoxide (CO) has gained recent attention as therapy to reduce the deleterious effects of CPB. We hypothesized that 1) CPB results in impaired neuromuscular transmission and reduced diaphragm force generation; and 2) CO treatment during CPB will mitigate these effects. In adult male Sprague-Dawley rats, diaphragm muscle-specific force and neuromuscular transmission properties were measured 90 min after weaning from normothermic CPB (1 h). During CPB, either low-dose inhaled CO (250 ppm) or air was administered. The short period of mechanical ventilation used in the present study (∼3 h) did not adversely affect diaphragm muscle contractile properties or neuromuscular transmission. CPB elicited a significant decrease in isometric diaphragm muscle-specific force compared with time-matched, mechanically ventilated rats (∼25% decline in both twitch and tetanic force). Diaphragm muscle fatigability to 40-Hz repetitive stimulation did not change significantly. Neuromuscular transmission failure during repetitive activation was 60 ± 2% in CPB animals compared with 76 ± 4% in mechanically ventilated rats ( P < 0.05). CO treatment during CPB abrogated the neuromuscular effects of CPB, such that diaphragm isometric twitch force and neuromuscular transmission were no longer significantly different from mechanically ventilated rats. Thus, CPB has important detrimental effects on diaphragm muscle contractility and neuromuscular transmission that are largely mitigated by CO treatment. Further studies are needed to ascertain the underlying mechanisms of CPB-induced neuromuscular dysfunction and to establish the potential role of CO therapy.

Style APA, Harvard, Vancouver, ISO itp.

41

Grishin, S. N., A. E. Khairullin, A. Y. Teplov i M. A. Mukhamedyarov. "Neuromuscular Transmission in a Barium Environment". Biophysics 67, nr 3 (czerwiec 2022): 457–60. http://dx.doi.org/10.1134/s000635092203006x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Stanec, A., i T. Baker. "Physiology and pharmacology of neuromuscular transmission". Current Opinion in Anaesthesiology 2, nr 4 (sierpień 1989): 470–73. http://dx.doi.org/10.1097/00001503-198908000-00018.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Engbæk, J. "Measurement and monitoring of neuromuscular transmission". Current Opinion in Anaesthesiology 3, nr 4 (sierpień 1990): 625–29. http://dx.doi.org/10.1097/00001503-199003040-00022.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Engbæk, J. "Measurement and monitoring of neuromuscular transmission". Current Opinion in Anaesthesiology 3, nr 4 (sierpień 1990): 625–29. http://dx.doi.org/10.1097/00001503-199008000-00022.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Kopman, David, i Cynthia A. Lien. "Physiology and Pharmacology of Neuromuscular Transmission". ASA Refresher Courses in Anesthesiology 37, nr 1 (lipiec 2009): 107–17. http://dx.doi.org/10.1097/asa.0b013e3181a6898d.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Ertas, Mustafa, i M. Baris Baslo. "Abnormal Neuromuscular Transmission in Cluster Headache". Headache: The Journal of Head and Face Pain 43, nr 6 (czerwiec 2003): 616–20. http://dx.doi.org/10.1046/j.1526-4610.2003.03103.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

LOAN, P. B., L. D. PAXTON, R. K. MIRAKHUR, F. M. CONNOLLY i E. P. McCOY. "The TOF-Guard neuromuscular transmission monitor." Anaesthesia 50, nr 8 (sierpień 1995): 699–702. http://dx.doi.org/10.1111/j.1365-2044.1995.tb06097.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Ross, R. "Neuromuscular transmission in the 17th century". Journal of Neurology, Neurosurgery & Psychiatry 51, nr 10 (1.10.1988): 1268. http://dx.doi.org/10.1136/jnnp.51.10.1268.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Klose, M. K. "Stress-Induced Thermoprotection of Neuromuscular Transmission". Integrative and Comparative Biology 44, nr 1 (1.02.2004): 14–20. http://dx.doi.org/10.1093/icb/44.1.14.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Massey, Janice. "Electromyography in Disorders of Neuromuscular Transmission". Seminars in Neurology 10, nr 01 (marzec 1990): 6–11. http://dx.doi.org/10.1055/s-2008-1041247.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!